Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 10.59B 1.59B 1.41B 1.31B 1.19B 2.25B 151B 2.28B 15.75B 6.18B 78.67B 5.95B 5.83B 251B P/E 2026 *
15.9x
P/E 2027 * 14.3x
Enterprise Value 10.59B 1.59B 1.41B 1.31B 1.19B 2.25B 151B 2.28B 15.75B 6.18B 78.67B 5.95B 5.83B 251B EV / Sales 2026 *
2.52x
EV / Sales 2027 * 2.3x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day+0.70%
1 week+7.06%
Current month+9.10%
1 month+9.83%
3 months+0.37%
6 months-2.07%
Current year-12.25%
1 week 22.9
Extreme 22.9
24.98
1 month 22.12
Extreme 22.12
24.98
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
32.2
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 2019-05-27
Director of Finance/CFO 49 2023-12-27
Corporate Officer/Principal 40 2021-08-18
Director TitleAgeSince
Chairman 64 2010-03-15
Director/Board Member 48 2019-05-27
Director/Board Member 40 2022-06-13
Change 5-day change 1-year change 3-year change Capi.($)
+0.70%+7.06%-15.31%+8.67% 1.58B
+0.43%+6.59%+53.41%+103.85% 1,120B
+0.90%-2.25%+33.02%+62.23% 616B
+0.71%+3.24%+25.81%+93.86% 504B
-0.13%+5.98%+32.91%+50.39% 367B
+0.52%+0.24%+73.92%+40.15% 360B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 258B
-0.35%+4.25%+46.21%+50.76% 234B
-0.75%+3.32%+32.53%+97.21% 194B
Average -0.09%+3.67%+30.12%+56.35% 394.25B
Weighted average by Cap. +0.13%+3.83%+39.16%+71.41%

Financials

2026 *2027 *
Net sales 4.2B 629M 560M 519M 473M 891M 59.71B 906M 6.24B 2.45B 31.19B 2.36B 2.31B 99.35B 4.61B 690M 615M 569M 518M 977M 65.5B 993M 6.85B 2.69B 34.21B 2.59B 2.53B 109B
Net income 668M 99.97M 89.1M 82.46M 75.13M 142M 9.49B 144M 992M 389M 4.96B 375M 367M 15.79B 740M 111M 98.71M 91.36M 83.24M 157M 10.52B 159M 1.1B 431M 5.49B 416M 407M 17.5B
Net Debt - -
Projected Income Statement - Annual - Mayinglong Pharmaceutical Group Co., LTD.
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
26-10-16 CN¥24.57 +0.70% 7,864,179
26-10-15 CN¥24.40 -0.65% 9,686,415
26-10-14 CN¥24.56 +3.54% 11,589,960
26-10-13 CN¥23.72 +0.55% 8,212,280
26-10-12 CN¥23.59 +2.79% 7,276,758
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Mayinglong Pharmaceutical Group Co., LTD.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
24.57CNY
Average target price
37.74CNY
Spread / Average Target
+53.62%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Mayinglong Pharmaceutical Group Co., LTD.
  1. Stock Market
  2. Stocks
  3. 600993 Stock